Atipamezole hydrochloride Sterile Injectable Solution

HOW SUPPLIED: Production is supplied in 10-mL, multidose vials containing 5.0 mg of atipamezole hydrochloride per mL.

INDICATIONS: Indicated for the reversal of the sedative and analgesic effects of dexmedetomidine hydrochloride and medetomidine hydrochloride in dogs.

Atipamezole hydrochloride competitively inhibits alpha-2 adrenergic receptor, and is an effective alpha-2 adrenergic receptor blocker, which selectively and competitively inhibits alpha-2 adrenergic receptor. Its pharmacological effect is to reduce sedation, lower blood pressure, increase heart rate and respiratory rate, and reduce the analgesic effect of α2 adrenergic receptor blockers, mainly used in animal anesthesia recovery after surgery.

Only be used for scientific research, not for humans and animals.